| Citation: |
HU Zhen, LI Shengjin. Survival and Prognosis of Primary Mediastinal and Pulmonary Sarcoma Based on SEER Database[J]. Cancer Research on Prevention and Treatment, 2023, 50(11): 1091-1096. DOI: 10.3971/j.issn.1000-8578.2023.23.0419
|
To analyze the factors affecting the prognosis of soft tissue sarcomas originating from the mediastinum and lung using relevant data from the SEER database.
The data of 376 patients were collected from the SEER database, and were randomly divided into the train set (n=263) and validation set (n=113). The relationship between each variable and patient survival and prognosis was analyzed using the Kaplan-Meier method and Cox proportional risk regression to establish a nomogram, to predict the overall survival of patients. The calibration curves, consistency index, and ROC curves were used to evaluate the performance of the nomogram.
Histological type, surgery, chemotherapy, tumor size, and tumor stage were the factors affecting the prognosis of primary mediastinal and pulmonary soft tissue sarcomas. The established nomogram could predict the 6-month, 1-year, and 2-year overall survival of patients, and the calibration curves showed good prediction accuracy with measured values. C index of the train set and validation set were 0.754 and 0.745, respectively. The areas under the curve of ROC were 0.849 and 0.924.
The nomogram established in this study can predict 6-month, 1-year, and 2-year overall survival in patients with primary mediastinal and pulmonary soft tissue sarcoma.
Competing interests: The authors declare that they have no competing interests.
| [1] |
Gronchi A, Miah AB, Dei Tos AP, et al. Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol, 2021, 32(11): 1348-1365. doi: 10.1016/j.annonc.2021.07.006
|
| [2] |
Wu WT, Li YJ, Feng AZ, et al. Data mining in clinical big data: the frequently used databases, steps, and methodological models[J]. Mil Med Res, 2021, 8(1): 44.
|
| [3] |
Engelhardt KE, Decamp MM, Yang AD, et al. Treatment Approaches and Outcomes for Primary Mediastinal Sarcoma: Analysis of 976 Patients[J]. Ann Thorac Surg, 2018, 106(2): 333-339. doi: 10.1016/j.athoracsur.2018.03.068
|
| [4] |
von Mehren M, Kane JM, Agulnik M, et al. Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology[J]. J Natl Compr Canc Netw, 2022, 20(7): 815-833. doi: 10.6004/jnccn.2022.0035
|
| [5] |
Khalil M, Ahmed MT, Abouelasaad M, et al. A Disastrous Huge Anterior Mediastinal Synovial Sarcoma[J]. Cardiovasc Revasc Med, 2022, 37: 153-155. doi: 10.1016/j.carrev.2021.10.002
|
| [6] |
Collaud S, Stork T, Schildhaus HU, et al. Multimodality treatment including surgery for primary pulmonary sarcoma: Size does matter[J]. J Surg Oncol, 2020, 122(3): 506-514. doi: 10.1002/jso.25979
|
| [7] |
Cates JMM. The AJCC 8th Edition Staging System for Soft Tissue Sarcoma of the Extremities or Trunk: A Cohort Study of the SEER Database[J]. J Natl Compr Canc Netw, 2018, 16(2): 144-152. doi: 10.6004/jnccn.2017.7042
|
| [8] |
Lu J, Wood D, Ingley E, et al. Update on genomic and molecular landscapes of well-differentiated liposarcoma and dedifferentiated liposarcoma[J]. Mol Biol Rep, 2021, 48(4): 3637-3647. doi: 10.1007/s11033-021-06362-5
|
| [9] |
Foersch S, Eckstein M, Wagner DC, et al. Deep learning for diagnosis and survival prediction in soft tissue sarcoma[J]. Ann Oncol, 2021, 32(9): 1178-1187. doi: 10.1016/j.annonc.2021.06.007
|
| [10] |
Gong S, Schopow N, Duan Y, et al. PLOD Family: A Novel Biomarker for Prognosis and Personalized Treatment in Soft Tissue Sarcoma[J]. Genes (Basel), 2022, 13(5): 787. doi: 10.3390/genes13050787
|
| [11] |
牛晓辉, 徐海荣. 分子检测在骨与软组织肉瘤诊治中的必要性和迫切性[J]. 中华医学杂志, 2022, 102(31): 2399-2404.
Niu XH, Xu HR. The necessity and urgency of molecular analysis in the diagnosis and treatment of bone and soft tissue sarcomas[J]. Zhonghua Yi Xue Za Zhi, 2022, 102(31): 2399-2404.
|
| [12] |
Gronchi A. Surgery in soft tissue sarcoma: the thin line between a surgical or more conservative approach[J]. Future Oncol, 2021, 17(21s): 3-6. doi: 10.2217/fon-2021-0449
|
| [13] |
Salerno KE. Radiation Therapy for Soft Tissue Sarcoma: Indications, Timing, Benefits, and Consequences[J]. Surg Clin North Am, 2022, 102(4): 567-582. doi: 10.1016/j.suc.2022.04.001
|
| [14] |
Feng XY, Li J, Li AM, et al. Stereotactic body radiotherapy for recurrent and oligometastatic soft tissue sarcoma[J]. World J Surg Oncol, 2022, 20(1): 322. doi: 10.1186/s12957-022-02781-1
|
| [15] |
Virgili Manrique AC, Salazar J, Arranz MJ, et al. Pharmacogenetic Profiling in High-Risk Soft Tissue Sarcomas Treated with Neoadjuvant Chemotherapy[J]. J Pers Med, 2022, 12(4): 618. doi: 10.3390/jpm12040618
|
| [16] |
Meyer M, Seetharam M. First-Line Therapy for Metastatic Soft Tissue Sarcoma[J]. Curr Treat Options Oncol, 2019, 20(1): 6. doi: 10.1007/s11864-019-0606-9
|
| [17] |
Panagi M, Pilavaki P, Constantinidou A, et al. Immunotherapy in soft tissue and bone sarcoma: unraveling the barriers to effectiveness[J]. Theranostics, 2022, 12(14): 6106-6129. doi: 10.7150/thno.72800
|
| [1] | LIU Junqing, LEI Lingling, FU Yaru, SONG Xin, WANG Jingjing, ZHAO Xueke, LIU Min, FAN Zongmin, DAI Fangzhou, HAN Xuena, YANG Zhuo, ZHONG Kan, YANG Sai, ZHANG Qiang, BAO Qide, WANG Lidong. Summary of 16-Year Observation of Reflux Esophagitis-Like Symptoms in A Natural Village in A High-Incidence Area of Esophageal Cancer[J]. Cancer Research on Prevention and Treatment, 2025, 52(6): 461-465. DOI: 10.3971/j.issn.1000-8578.2025.24.1290 |
| [2] | LV Minhao, QIN Li, LI Juntao, GUO Xuhui, LIU Fawen, CUI Shude, ZHANG Hengwei. 原发性乳腺癌分子分型与新辅助化疗疗效及预后的相关性[J]. Cancer Research on Prevention and Treatment, 2015, 42(08): 782-788. DOI: 10.3971/j.issn.1000-8578.2015.08.007 |
| [3] | WEI Dong, LI Yan, QI Yan-yu, ZHANG Tao, LIU Huan-yi. Therapeutic-effect of Different Dosage of rmhTNF in Curing Malignancy Pericardial Effusion of Advanced Tumor[J]. Cancer Research on Prevention and Treatment, 2011, 38(09): 1066-1069. DOI: 10.3971/j.issn.1000-8578.2011.09.024 |
| [4] | WANG Da-fei, JIANG Ze-hua. The Therapeutic Effect of Injecting Bleomycin after Retaining the Central Venous Catheter in Thorax for Draining Cancerous Hydrothorax[J]. Cancer Research on Prevention and Treatment, 2006, 33(10): 765-766. DOI: 10.3971/j.issn.1000-8578.860 |
| [5] | ZHAO Chen-xing, ZHANG De-geng, HUANG Jun-xing, JI Xue-yuan, Qian Ying-chun, SHEN Bo, CHEN Ling-xiang, LIU Yu-fei. Therapeutic Effect of Oxaliplatin in the Treatment of Malignant Hydropericardium[J]. Cancer Research on Prevention and Treatment, 2006, 33(04): 270-271. DOI: 10.3971/j.issn.1000-8578.3381 |
| [8] | Zhang Qing-yuan, . Combined Chemotherapy inside Pericardium Treatment of Lung Carcinoma Pericardium Metastasis on the Basis of MF Scheme[J]. Cancer Research on Prevention and Treatment, 1995, 22(5): 305-306,304. |
| [9] | Dai Hongxi, . A Clinical Analysis of 50 cases with Cancerous Pleural Effusion[J]. Cancer Research on Prevention and Treatment, 1994, 21(3): 159-160. |
Figures(6) / Tables(1)
This work is licensed under a Creative Commons Attribution 3.0 License.
Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号
Supported by: Beijing Renhe Information Technology Co., Ltd. 
DownLoad: